Inventor

Vincent E. Groppi, Jr.

Inventor
Kalamazoo, MI, US

Overview

23→
Patents
1996–2007
Patent span
Chemistry
Primary field (CPC C)

Patents· 23 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations43%
C07DHeterocyclic compounds43%
C07KPeptides13%
C07CAcyclic or carbocyclic compounds3%
PatentTitleYear
7,247,706'Double mutant alpha-7 nicotinic acetylcholine receptors'20077,176,198'1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease'20077,067,515'Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease'20067,001,900'Azabicyclic compounds for the treatment of disease'20066,951,868'Azabicyclic-phenyl-fused-heterocyclic compounds for treatment of disease'20056,919,359'Azabicyclic-substituted-heteroaryl compounds for the treatment of disease'20056,869,946'Substituted azabicyclic moieties for the treatment of disease'20056,858,613'Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of disease'20056,852,716'Substituted-aryl compounds for treatment of disease'20056,849,620'N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease'20056,828,330'Quinuclidine-substituted hetero-bicyclic aromatic compounds for the treatment of disease'20046,693,172'Double mutant alpha-7 nicotinic acetylcholine receptor'20046,599,916'Quinuclidine-substituted heteroaryl moieties for treatment of disease'20036,562,816'Substituted-heteroaryl-7-aza2.2.1bicycloheptanes for the treatment of disease'20036,500,840'Quinuclidine-substituted heteroaryl moieties for treatment of disease'20026,492,386'Quinuclidine-substituted aryl compounds for treatment of disease'20026,492,385'Quinuclidine-substituted heteroaryl moieties for treatment of disease'20026,486,172'Quinuclidine-substituted aryl compounds for treatment of disease'20026,479,510'Quinuclidine-substituted aryl compounds for treatment of disease'20025,925,742'Protein affecting K.sub.ATP channels'19995,882,873'Human DNA sequence encoding a kidney ATP-dependent potassium channel'19995,856,449'Protein affecting K.sub.ATP channels'19995,525,742'Azidophenylcyanoguanidines as photoaffinity probes'1996

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1996–2007Patents assigned to UPJOHN CO (14)· patent assignee history
1996–2007Based in Kalamazoo, MI, US· patent location history
1999Based in Kalamozoo, MI, US· patent location history
2005–2007Patents assigned to PFIZER (9)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
UPJOHN CO141996–2007
PFIZER92005–2007
Locations
LocationPatentsSpan
Kalamazoo, MI, US221996–2007
Kalamozoo, MI, US11999